The National Institute of Biomedical Imaging and Bioengineering (NIBIB) announces that its Point-of-Care Technology Research Network (POCTRN) is soliciting proposals to further advance HIV viral load (VL) detection technologies in order to fill specific unmet national and global needs. Under this solicitation, NIBIB is seeking proposals to accelerate the validation and prototyping of innovative HIV VL testing platforms that are designed for use at the point-of-care that fill unmet national and global needs with a level of analytical performance—especially for VL limit of detection—that facilitates monitoring people with HI V (PWH) on antiretroviral treatment (ART) and accurately assessing ineffectiveness. Proposed solutions with optimized design, performance, and sample collection for infants are welcome but not required, as are platforms that employ innovative sampling methods.
Read more about POCTRN HIV Viral Load Testing at Point-of-Care at https://www.poctrn.org/hiv-viral-load-testing.
What Is VentureWell’s Role in HIV Viral Load Testing at Point-of-Care?
VentureWell serves as a critical facilitator within the HIV Viral Load Testing at Point-of-Care initiative, leveraging its network and expertise to identify, assess, select, and contract vendors and professional service consultants.
VentureWell’s role includes providing vital infrastructure support and commercialization services for RADx innovators, aiding the further advance of HIV viral load detection technologies in order to fill specific unmet national and global needs.